PRF1 and neoplasm: Firstly, IL-18 activates natural killer (NK) cells and certain subsets of T cells, enhancing their cytotoxic activity against tumor cells by upregulating cytotoxic molecules such as perforin and granzymes, which are crucial for direct tumor cell killing (54).